BSE filing, NSE: CHORDIA. Summary written from the filing by ALFA Finder's alert engine.
Chordia Food Products Ltd: key numbers
- Share price
- ₹100.40
- Market cap
- ₹40.44 Cr
- Revenue (annual)
- ₹4.77 Cr
- Net profit (annual)
- ₹0.78 Cr
- P/E (TTM)
- 71.7×Sector 40.4×
- Promoter holding
- 73.08%+0.47% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chordia Food Products Ltd
All →Chordia Food Products Q2 FY27 Results: Net Profit ₹0 Cr
Chordia Food Products Ltd reported revenue from operations of ₹0.8 Cr (-11.1% YoY) and net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr
Chordia Food Products Board Meeting Date
Chordia Food Products will hold a board meeting on 3 November 2026. It will consider unaudited financial results for the quarter and half-year ended 30 September 2026.
Chordia Food Products Other Announcement
Chordia Food Products Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026, as required under SEBI regulations.
Chordia Food Products Annual General Meeting
Chordia Food Products concluded its 44th Annual General Meeting. Shareholders adopted the financial statements and re-appointed Mr. Pradeep Chordia as Chairman and Managing Director.
Chordia Food Products Annual Report
Chordia Food Products Ltd has filed its Annual Report for the financial year ended March 31, 2026, and notice for its 44th Annual General Meeting.
Chordia Food Products Annual General Meeting
Chordia Food Products has scheduled its 44th Annual General Meeting for September 26, 2026. Book closure for the AGM is set from September 19 to September 26, 2026.
Other other announcement announcements
All →Transchem Other Announcement
Transchem's monitoring agency reports no deviation in warrant proceeds utilisation for the quarter ended September 2026. No material facts were flagged.
Archidply Industries Other Announcement
Archidply Industries disclosed that its RTA, KFin Technologies, is shifting its corporate office to Kokapet, Hyderabad from December 1, 2026. The registered office is unchanged and shareholders should update correspondence addresses.
KEI Industries Other Announcement
Designated person Jashobant Singha Ray pledged 1,500 KEI Industries shares. After the transaction, 10,000 of his 18,000 shares are pledged, with no cash consideration disclosed.
Kansai Nerolac Paints Other Announcement
Kansai Nerolac authorised Pravin Chaudhari, Yash Ahuja and Rukmini Subramanian to determine material events from 1 December 2026. It only lists KMP and contact details.
Glenmark Pharmaceuticals Other Announcement
Glenmark's partner IGI will present updated Phase 1 clinical data for ISB 2001 (ABBV-2001) in relapsed/refractory multiple myeloma at the 68th ASH Annual Meeting. The presentation is scheduled for December 12, 2026.
Vineet Laboratories Other Announcement
Vineet Laboratories' board appointed SVRL & Co. as statutory auditors, subject to shareholder approval. The five-year term runs from the 10th AGM to the 16th AGM.